TP53 and central nervous system cancer: In particular, clonogenic survival assays of chromosomally stable HCT116p53−/−/PSCA colorectal cancer cells and chromosomally instable H4PSCA glioma cells demonstrated significant decreased cell survival in response to targeted transposition of TP53 in vitro using our PSCA-specific hybrid polyplexes.